Literature DB >> 18781940

Fluorescent GPCR ligands as new tools in pharmacology.

Kamil Kuder1, Katarzyna Kieć-Kononowicz.   

Abstract

The expansion of fluorescent techniques for studying the ligand-receptor interaction resulted in a burst of the novel fluorescent ligands development. The discovery of the ligand, that is of high affinity to the receptor and whose localization could be easily visualized, even on the single cell level, gave the researchers a strong impulse to investigate that field of GPCR ligands. Moreover, paying attention to the "non pharmacological" advantages of these ligands, as well as the techniques to be used, fluorescent ligands are becoming treated more seriously, as the ligands themselves, and as novel, useful tools for studying GPCRs. Herein, we review results described in the literature, starting from the year 2000, in the field of the fluorescent GPCR small, non-peptide ligands according to the affinity to the selected receptors (histamine, adenosine, adrenergic, cannabinoid, muscarinie, neuropeptide Y and serotonine) as well as the fluorophores that have been used to tag the molecules.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18781940     DOI: 10.2174/092986708785747599

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  21 in total

1.  Novel fluorescent antagonist as a molecular probe in A(3) adenosine receptor binding assays using flow cytometry.

Authors:  Eszter Kozma; T Santhosh Kumar; Stephanie Federico; Khai Phan; Ramachandran Balasubramanian; Zhan-Guo Gao; Silvia Paoletta; Stefano Moro; Giampiero Spalluto; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2012-03-01       Impact factor: 5.858

Review 2.  The evolving small-molecule fluorescent-conjugate toolbox for Class A GPCRs.

Authors:  Andrea J Vernall; Stephen J Hill; Barrie Kellam
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

3.  Search for novel, high affinity histamine H3 receptor ligands with fluorescent properties.

Authors:  K J Kuder; T Kottke; H Stark; X Ligneau; J-C Camelin; R Seifert; K Kieć-Kononowicz
Journal:  Inflamm Res       Date:  2010-03       Impact factor: 4.575

4.  Discovery of Quinazoline-Based Fluorescent Probes to α1-Adrenergic Receptors.

Authors:  Wei Zhang; Zhao Ma; Wenhua Li; Geng Li; Laizhong Chen; Zhenzhen Liu; Lupei Du; Minyong Li
Journal:  ACS Med Chem Lett       Date:  2015-03-30       Impact factor: 4.345

5.  Original Design of Fluorescent Ligands by Fusing BODIPY and Melatonin Neurohormone.

Authors:  Jérémy Thireau; Justine Marteaux; Philippe Delagrange; Francois Lefoulon; Laurence Dufourny; Gérald Guillaumet; Franck Suzenet
Journal:  ACS Med Chem Lett       Date:  2013-11-20       Impact factor: 4.345

Review 6.  Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors.

Authors:  Rajashri Sridharan; Jeffrey Zuber; Sara M Connelly; Elizabeth Mathew; Mark E Dumont
Journal:  Biochim Biophys Acta       Date:  2013-09-18

7.  Synthesis of BODIPY derivatives substituted with various bioconjugatable linker groups: a construction kit for fluorescent labeling of receptor ligands.

Authors:  Fabian Heisig; Sabrina Gollos; Sven J Freudenthal; Ali El-Tayeb; Jamshed Iqbal; Christa E Müller
Journal:  J Fluoresc       Date:  2013-09-20       Impact factor: 2.217

Review 8.  Fluorescent ligands for adenosine receptors.

Authors:  Eszter Kozma; P Suresh Jayasekara; Lucia Squarcialupi; Silvia Paoletta; Stefano Moro; Stephanie Federico; Giampiero Spalluto; Kenneth A Jacobson
Journal:  Bioorg Med Chem Lett       Date:  2012-11-05       Impact factor: 2.823

Review 9.  Structure-function studies with G protein-coupled receptors as a paradigm for improving drug discovery and development of therapeutics.

Authors:  Patrick M McNeely; Andrea N Naranjo; Anne S Robinson
Journal:  Biotechnol J       Date:  2012-12       Impact factor: 4.677

Review 10.  Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).

Authors:  Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2009-04-30       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.